Progression of site-specific recurrence of pancreatic cancer and implications for treatment

Objective: To analyze postrecurrence progression in the context of recurrence sites and assess implications for postrecurrence treatment. - Background: Most patients with resected pancreatic ductal adenocarcinoma (PDAC) recur within 2 years. Different survival outcomes for location-specific patterns...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Rompen, Ingmar F. (VerfasserIn) , Levine, Jonah (VerfasserIn) , Habib, Joseph R. (VerfasserIn) , Sereni, Elisabetta (VerfasserIn) , Mughal, Nabiha (VerfasserIn) , Hewitt, Daniel Brock (VerfasserIn) , Sacks, Greg D. (VerfasserIn) , Welling, Theodore H. (VerfasserIn) , Simeone, Diane M. (VerfasserIn) , Kaplan, Brian (VerfasserIn) , Berman, Russell S. (VerfasserIn) , Cohen, Steven M. (VerfasserIn) , Wolfgang, Christopher L. (VerfasserIn) , Javed, Ammar A. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 2024
In: Annals of surgery
Year: 2024, Jahrgang: 280, Heft: 2, Pages: 317-324
ISSN:1528-1140
DOI:10.1097/SLA.0000000000006142
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/SLA.0000000000006142
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/annalsofsurgery/fulltext/2024/08000/progression_of_site_specific_recurrence_of.21.aspx
Volltext
Verfasserangaben:Ingmar F. Rompen, Jonah Levine, Joseph R. Habib, Elisabetta Sereni, Nabiha Mughal, Daniel Brock Hewitt, Greg D. Sacks, Theodore H. Welling, Diane M. Simeone, Brian Kaplan, Russell S. Berman, Steven M. Cohen, Christopher L. Wolfgang, and Ammar A. Javed

MARC

LEADER 00000caa a2200000 c 4500
001 1925326888
003 DE-627
005 20250913141519.0
007 cr uuu---uuuuu
008 250512s2024 xx |||||o 00| ||eng c
024 7 |a 10.1097/SLA.0000000000006142  |2 doi 
035 |a (DE-627)1925326888 
035 |a (DE-599)KXP1925326888 
035 |a (OCoLC)1528045012 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Rompen, Ingmar F.  |d 1994-  |e VerfasserIn  |0 (DE-588)1260414086  |0 (DE-627)1807281671  |4 aut 
245 1 0 |a Progression of site-specific recurrence of pancreatic cancer and implications for treatment  |c Ingmar F. Rompen, Jonah Levine, Joseph R. Habib, Elisabetta Sereni, Nabiha Mughal, Daniel Brock Hewitt, Greg D. Sacks, Theodore H. Welling, Diane M. Simeone, Brian Kaplan, Russell S. Berman, Steven M. Cohen, Christopher L. Wolfgang, and Ammar A. Javed 
264 1 |c August 2024 
264 4 |c © 2023 
300 |b Illustrationen 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 12.05.2025 
520 |a Objective: To analyze postrecurrence progression in the context of recurrence sites and assess implications for postrecurrence treatment. - Background: Most patients with resected pancreatic ductal adenocarcinoma (PDAC) recur within 2 years. Different survival outcomes for location-specific patterns of recurrence are reported, highlighting their prognostic value. However, a lack of understanding of postrecurrence progression and survival remains. - Methods: This retrospective analysis included surgically treated patients with PDAC at NYU Langone Health (2010-2021). Sites of recurrence were identified at the time of diagnosis and further follow-up. Kaplan-Meier curves, log-rank test, and Cox regression analyses were applied to assess survival outcomes. - Results: Recurrence occurred in 57.3% (196/342) patients with a median time to recurrence of 11.3 months (95% CI: 12.6-16.5). The first site of recurrence was local in 43.9% of patients, liver in 23.5%, peritoneal in 8.7%, lung in 3.6%, whereas 20.4% had multiple sites of recurrence. Progression to secondary sites was observed in 11.7%. Only lung involvement was associated with significantly longer survival after recurrence compared with other sites (16.9 vs 8.49 months, P = 0.003). In local recurrence, 21 (33.3%) patients were alive after 1 year without progression to secondary sites. This was associated with a CA19-9 of <100 U/mL at the time of primary diagnosis (P = 0.039), nodal negative disease (P = 0.023), and well-moderate differentiation (P = 0.042) compared with patients with progression. - Conclusion: Except for lung recurrence, postrecurrence survival after PDAC resection is associated with poor survival. A subset of patients with local-only recurrence do not quickly succumb to systemic spread. This is associated with markers for favorable tumor biology, making them candidates for potential curative re-resections when feasible. 
700 1 |a Levine, Jonah  |e VerfasserIn  |4 aut 
700 1 |a Habib, Joseph R.  |e VerfasserIn  |4 aut 
700 1 |a Sereni, Elisabetta  |e VerfasserIn  |4 aut 
700 1 |a Mughal, Nabiha  |e VerfasserIn  |4 aut 
700 1 |a Hewitt, Daniel Brock  |e VerfasserIn  |4 aut 
700 1 |a Sacks, Greg D.  |e VerfasserIn  |4 aut 
700 1 |a Welling, Theodore H.  |e VerfasserIn  |4 aut 
700 1 |a Simeone, Diane M.  |e VerfasserIn  |4 aut 
700 1 |a Kaplan, Brian  |e VerfasserIn  |4 aut 
700 1 |a Berman, Russell S.  |e VerfasserIn  |4 aut 
700 1 |a Cohen, Steven M.  |e VerfasserIn  |4 aut 
700 1 |a Wolfgang, Christopher L.  |e VerfasserIn  |0 (DE-588)1077118961  |0 (DE-627)836041518  |0 (DE-576)446002682  |4 aut 
700 1 |a Javed, Ammar A.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Annals of surgery  |d [Erscheinungsort nicht ermittelbar] : Lippincott Williams & Wilkins, 1885  |g 280(2024), 2 vom: Aug., Seite 317-324  |h Online-Ressource  |w (DE-627)313115222  |w (DE-600)2002200-1  |w (DE-576)090881796  |x 1528-1140  |7 nnas  |a Progression of site-specific recurrence of pancreatic cancer and implications for treatment 
773 1 8 |g volume:280  |g year:2024  |g number:2  |g month:08  |g pages:317-324  |g extent:8  |a Progression of site-specific recurrence of pancreatic cancer and implications for treatment 
856 4 0 |u https://doi.org/10.1097/SLA.0000000000006142  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.lww.com/annalsofsurgery/fulltext/2024/08000/progression_of_site_specific_recurrence_of.21.aspx  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250512 
993 |a Article 
994 |a 2024 
998 |g 1260414086  |a Rompen, Ingmar F.  |m 1260414086:Rompen, Ingmar F.  |d 910000  |d 910200  |e 910000PR1260414086  |e 910200PR1260414086  |k 0/910000/  |k 1/910000/910200/  |p 1  |x j 
999 |a KXP-PPN1925326888  |e 4723535748 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"given":"Ingmar F.","role":"aut","family":"Rompen","display":"Rompen, Ingmar F."},{"display":"Levine, Jonah","family":"Levine","given":"Jonah","role":"aut"},{"family":"Habib","display":"Habib, Joseph R.","role":"aut","given":"Joseph R."},{"display":"Sereni, Elisabetta","family":"Sereni","given":"Elisabetta","role":"aut"},{"family":"Mughal","display":"Mughal, Nabiha","role":"aut","given":"Nabiha"},{"display":"Hewitt, Daniel Brock","family":"Hewitt","role":"aut","given":"Daniel Brock"},{"display":"Sacks, Greg D.","family":"Sacks","role":"aut","given":"Greg D."},{"family":"Welling","display":"Welling, Theodore H.","given":"Theodore H.","role":"aut"},{"family":"Simeone","display":"Simeone, Diane M.","given":"Diane M.","role":"aut"},{"family":"Kaplan","display":"Kaplan, Brian","given":"Brian","role":"aut"},{"given":"Russell S.","role":"aut","display":"Berman, Russell S.","family":"Berman"},{"display":"Cohen, Steven M.","family":"Cohen","given":"Steven M.","role":"aut"},{"family":"Wolfgang","display":"Wolfgang, Christopher L.","role":"aut","given":"Christopher L."},{"family":"Javed","display":"Javed, Ammar A.","given":"Ammar A.","role":"aut"}],"id":{"eki":["1925326888"],"doi":["10.1097/SLA.0000000000006142"]},"relHost":[{"recId":"313115222","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2002200-1"],"issn":["1528-1140"],"eki":["313115222"]},"pubHistory":["1.1885 -"],"origin":[{"publisherPlace":"[Erscheinungsort nicht ermittelbar] ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1885-","dateIssuedKey":"1885","publisher":"Lippincott Williams & Wilkins ; Ovid"}],"note":["Gesehen am 26.09.18"],"title":[{"title":"Annals of surgery","title_sort":"Annals of surgery","subtitle":"a monthly review of surgical science and practice"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Progression of site-specific recurrence of pancreatic cancer and implications for treatmentAnnals of surgery","language":["eng"],"part":{"volume":"280","extent":"8","text":"280(2024), 2 vom: Aug., Seite 317-324","issue":"2","pages":"317-324","year":"2024"}}],"recId":"1925326888","physDesc":[{"noteIll":"Illustrationen","extent":"8 S."}],"name":{"displayForm":["Ingmar F. Rompen, Jonah Levine, Joseph R. Habib, Elisabetta Sereni, Nabiha Mughal, Daniel Brock Hewitt, Greg D. Sacks, Theodore H. Welling, Diane M. Simeone, Brian Kaplan, Russell S. Berman, Steven M. Cohen, Christopher L. Wolfgang, and Ammar A. Javed"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Progression of site-specific recurrence of pancreatic cancer and implications for treatment","title_sort":"Progression of site-specific recurrence of pancreatic cancer and implications for treatment"}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"August 2024"}],"note":["Gesehen am 12.05.2025"]} 
SRT |a ROMPENINGMPROGRESSIO2024